Brief: AVROBIO To Present Clinical And Preclinical Data From Lysosomal Disorder Gene Therapy Pipeline
09/02/2023 13:17
Feb 9 (Reuters) - AVROBIO Inc AVRO.O :
* AVROBIO TO PRESENT CLINICAL AND PRECLINICAL DATA FROM
LYSOSOMAL
DISORDER GENE THERAPY PIPELINE AT WORLDSYMPOSIUM™ 2023
Source text for Eikon: ID:nBw3DwQ6Ra
Further company coverage: AVRO.O
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs